Short Interest in Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Decreases By 18.6%

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHFGet Rating) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 45,900 shares, a drop of 18.6% from the April 30th total of 56,400 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Kissei Pharmaceutical stock remained flat at $$18.03 during mid-day trading on Tuesday. Kissei Pharmaceutical has a 52-week low of $18.03 and a 52-week high of $21.10. The business has a fifty day moving average price of $19.31 and a 200 day moving average price of $19.74.

Kissei Pharmaceutical Company Profile (Get Rating)

Kissei Pharmaceutical Co, Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. It offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes, and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment of renal anemia; Beova tablets for overactive bladder treatment; P-TOL chewable tablets for treating hyperphosphatemia; and Minirin Melt OD tablets for nocturia due to nocturnal polyuria in males, central diabetes insipidus, and nocturnal enuresis resulted from decrease of urine osmolality.

See Also

Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.